In conjunction with the aforementioned pathogenic mechanism in molecular biology, significant focus has been placed on MMR-related genes as well as RAS and BRAF as valuable molecular markers for clinical diagnosis and treatment of CRC. This evidence concerns the gene BRAF and colorectal carcinoma.